Key Takeaways
- • New Mountain Capital merged three healthcare technology companies—The Rawlings Group, Apixio's Payment Integrity business, and Varis—in a deal valued at over $3 billion to create a dominant player in the payment integrity market.
- • The combined entity will employ close to 2,000 employees and integrate complementary capabilities including subrogation, coordination of benefits, pharmacy payment integrity, complex claim solutions, and overpayment identification across prospective payment systems.
- • The Rawlings Group, a 40-year-old incumbent with 1,600 employees and deep relationships with major U.S. health insurers, serves as the anchor asset in the combination, with Apixio's AI-driven technology and Varis's DRG/APC expertise layered on top.
- • Centene divested Apixio's Payment Integrity business to New Mountain Capital approximately one year prior; the broader Apixio platform was split, with connected care and value-based services transferred to Datavant as part of separate deal structuring.
- • The consolidation reflects private equity's strategic interest in healthcare technology infrastructure, particularly in payment accuracy and claims management, where scale and technological integration create competitive advantages among health plan customers.
Summary
New Mountain Capital has executed a significant consolidation in healthcare payment integrity by merging three specialized technology firms into a single entity valued at more than $3 billion. The combination brings together The Rawlings Group, Apixio's Payment Integrity division (acquired from Centene approximately one year ago), and Varis into an unnamed combined company positioned to serve as a top-tier competitor in the fast-growing payment integrity market.
The Rawlings Group serves as the foundational asset in this merger, contributing four decades of operational history, 1,600 employees, and established relationships with many of the largest U.S. health plans. The company specializes in subrogation and identifying third-party liability for medical claims. Apixio brings artificial intelligence-driven capabilities focused on improving administrative, clinical, and financial programs for health plans, while Varis contributes specialized expertise in overpayment identification across diagnosis-related groups (DRG) and ambulatory payment classification (APC) prospective payment systems.
The combined entity will employ approximately 2,000 people and offer a comprehensive suite of payment integrity solutions addressing multiple pain points in health plan operations. These capabilities span subrogation, coordination of benefits management, pharmacy payment integrity, complex claim resolution, and systematic overpayment detection. The consolidation allows New Mountain Capital to aggregate complementary technological and operational capabilities that individually target specific components of the claims and payment verification workflow.
The transaction reflects private equity's sustained focus on healthcare infrastructure, particularly on administrative and operational efficiency within health plan operations. Payment integrity—the identification and correction of improper payments—represents a substantial cost-reduction opportunity for health insurers, making this sector attractive to institutional capital. The scale created by this three-way merger positions the combined company to compete more effectively with both incumbent vendors and emerging competitors in serving the nation's largest health plans.
Notably, the broader Apixio platform was divided in the transaction, with its connected care platform and value-based care services transferred to Datavant as part of separate deal arrangements, allowing New Mountain to focus the merged entity specifically on payment integrity rather than broader care coordination services.
The Rawlings Group serves as the foundational asset in this merger, contributing four decades of operational history, 1,600 employees, and established relationships with many of the largest U.S. health plans. The company specializes in subrogation and identifying third-party liability for medical claims. Apixio brings artificial intelligence-driven capabilities focused on improving administrative, clinical, and financial programs for health plans, while Varis contributes specialized expertise in overpayment identification across diagnosis-related groups (DRG) and ambulatory payment classification (APC) prospective payment systems.
The combined entity will employ approximately 2,000 people and offer a comprehensive suite of payment integrity solutions addressing multiple pain points in health plan operations. These capabilities span subrogation, coordination of benefits management, pharmacy payment integrity, complex claim resolution, and systematic overpayment detection. The consolidation allows New Mountain Capital to aggregate complementary technological and operational capabilities that individually target specific components of the claims and payment verification workflow.
The transaction reflects private equity's sustained focus on healthcare infrastructure, particularly on administrative and operational efficiency within health plan operations. Payment integrity—the identification and correction of improper payments—represents a substantial cost-reduction opportunity for health insurers, making this sector attractive to institutional capital. The scale created by this three-way merger positions the combined company to compete more effectively with both incumbent vendors and emerging competitors in serving the nation's largest health plans.
Notably, the broader Apixio platform was divided in the transaction, with its connected care platform and value-based care services transferred to Datavant as part of separate deal arrangements, allowing New Mountain to focus the merged entity specifically on payment integrity rather than broader care coordination services.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.